264 related articles for article (PubMed ID: 35128762)
1. The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis.
Soysal P; Smith L; Trott M; Alexopoulos P; Barbagallo M; Tan SG; Koyanagi A; Shenkin S; Veronese N;
Psychogeriatrics; 2022 May; 22(3):402-412. PubMed ID: 35128762
[TBL] [Abstract][Full Text] [Related]
2. [Neuropsychiatric symptoms in people living with dementia related to COVID-19 pandemic lockdown. Exploratory systematic review].
Sánchez-García M; Rodríguez-Del Rey T; Pérez-Sáez E; Gay-Puente FJ
Rev Neurol; 2022 Feb; 74(3):83-92. PubMed ID: 35084733
[TBL] [Abstract][Full Text] [Related]
3. Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? A systematic review and meta-analysis.
Mallo SC; Patten SB; Ismail Z; Pereiro AX; Facal D; Otero C; Juncos-Rabadán O
Ageing Res Rev; 2020 Mar; 58():101004. PubMed ID: 31881368
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric Symptoms in Mild Cognitive Impairment: A Literature Review.
Martin E; Velayudhan L
Dement Geriatr Cogn Disord; 2020; 49(2):146-155. PubMed ID: 32289790
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
Lara B; Carnes A; Dakterzada F; Benitez I; Piñol-Ripoll G
Eur J Neurol; 2020 Sep; 27(9):1744-1747. PubMed ID: 32449791
[TBL] [Abstract][Full Text] [Related]
7. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
8. The impact of COVID-19 pandemic on elderly with neurocognitive disorders.
Basta M; Skourti E
Psychiatriki; 2023 Oct; 34(3):177-180. PubMed ID: 37449850
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima, Peru.
Custodio N; Malaga M; Montesinos R; Chambergo D; Baca F; Castro S; Carbajal JC; Herrera E; Lira D; Diaz MM; Lanata S
Curr Alzheimer Res; 2023; 20(2):80-88. PubMed ID: 37073648
[TBL] [Abstract][Full Text] [Related]
10. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study.
Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG
BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304
[TBL] [Abstract][Full Text] [Related]
11. Instrumental Activities of Daily Living, Neuropsychiatric Symptoms, and Neuropsychological Impairment in Mild Cognitive Impairment.
Ginsberg TB; Powell L; Emrani S; Wasserman V; Higgins S; Chopra A; Cavalieri TA; Libon DJ
J Am Osteopath Assoc; 2019 Feb; 119(2):96-101. PubMed ID: 30688355
[TBL] [Abstract][Full Text] [Related]
12. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.
Qiu J; Goldstein FC; Hanfelt JJ
Am J Geriatr Psychiatry; 2022 Aug; 30(8):925-934. PubMed ID: 35067420
[TBL] [Abstract][Full Text] [Related]
13. Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment.
Mallo SC; Ismail Z; Pereiro AX; Facal D; Lojo-Seoane C; Campos-Magdaleno M; Juncos-Rabadán O
J Alzheimers Dis; 2018; 66(1):83-95. PubMed ID: 30175974
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia.
Forrester SN; Gallo JJ; Smith GS; Leoutsakos JM
Am J Geriatr Psychiatry; 2016 Feb; 24(2):117-25. PubMed ID: 26209222
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric symptoms in older people with and without cognitive impairment.
Brodaty H; Heffernan M; Draper B; Reppermund S; Kochan NA; Slavin MJ; Trollor JN; Sachdev PS
J Alzheimers Dis; 2012; 31(2):411-20. PubMed ID: 22571979
[TBL] [Abstract][Full Text] [Related]
16. The Impact of the COVID-19 Pandemic on the Psychological Well-Being of Caregivers of People with Dementia or Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
Soysal P; Veronese N; Smith L; Chen Y; Akpinar Soylemez B; Coin A; Religa D; Välimäki T; Alves M; Shenkin SD
Geriatrics (Basel); 2023 Sep; 8(5):. PubMed ID: 37887970
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
Lyketsos CG; Lopez O; Jones B; Fitzpatrick AL; Breitner J; DeKosky S
JAMA; 2002 Sep; 288(12):1475-83. PubMed ID: 12243634
[TBL] [Abstract][Full Text] [Related]
18. Effect of COVID-19 quarantine on cognitive, functional and neuropsychiatric symptoms in patients with mild cognitive impairment and dementia.
Vernuccio L; Sarà D; Inzerillo F; Catanese G; Catania A; Vesco M; Cacioppo F; Dominguez LJ; Veronese N; Barbagallo M
Aging Clin Exp Res; 2022 May; 34(5):1187-1194. PubMed ID: 35325450
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
